Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 5,588Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4A. Menarini

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Delafloxacin

Brand Name : Quofenix

Dosage Form : Tablet

Dosage Strength : 450mg

Packaging :

Approval Date : 28/05/2020

Application Number : 67238

Regulatory Info : Allowed

Registration Country : Switzerland

blank

02

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Delafloxacin

Brand Name : Quofenix

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 300mg

Packaging :

Approval Date : 28/05/2020

Application Number : 67239

Regulatory Info : Allowed

Registration Country : Switzerland

blank

03

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Delafloxacin Meglumine

Brand Name : Quofenix

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 300mg

Packaging :

Approval Date : 16/12/2019

Application Number : 20180307000140

Regulatory Info : Approved

Registration Country : Sweden

blank

04

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Delafloxacin Meglumine

Brand Name : Quofenix

Dosage Form : Tablet

Dosage Strength : 450mg

Packaging :

Approval Date : 16/12/2019

Application Number : 20180307000157

Regulatory Info : Approved

Registration Country : Sweden

blank